Narcan Spray
NDC Package 85766-076-02

11-digit billing NDC: 85766007602

Package Information

Narcan (naloxone hydrochloride nasal) sprays is nARCAN ® Naloxone HCl Nasal Spray 4 mg Emergency Treatment of Opioid OverdoseImportant:For use in the nose onlyDo not test nasal spray device before use1 nasal spray device contains 1 dose of medicineEach device sprays 1 time onlyStep 1: CHECK if you suspect an overdose:CHECKfor a suspected overdose:the person will not wake up or is very sleepy or not breathing well yell “Wake up!”shake the person gentlyif the person is not awake, go to Step 2Step 2: Give 1st dose in the noseHOLDthe nasal spray device with your thumb on the bottom of the plunger INSERTthe nozzle into either NOSTRIL PRESSthe plunger firmly to give the 1st dose 1 nasal spray device contains 1 doseStep 3: CALL 911CALL 911immediately after giving the l stdose Step 4: WATCH & GIVEWAIT2-3 minutes after the l stdose to give the medicine time to work if the person wakes up: Go to Step 5 if the person does not wake up: CONTINUE TO GIVEdoses every 2-3 minutes until the person wakes up it is safe to keep giving dosesStep 5: STAYSTAYuntil ambulance arrives: even if the person wakes up GIVEanother dose if the person becomes very sleepy again You may need to give all the doses in the packFor opioid emergencies, call 911.For questions on NARCAN, call 1-844-4NARCAN (1-844-462-7226) or go to www.narcan.com. This formulation utilizes a spray delivery system. Marketed by Sportpharm Llc, this product is identified by NDC 85766-076 and is authorized under FDA application NDA208411.

Identification & Billing

NDC Package Code
85766-076-02
Package Description
2 VIAL, SINGLE-DOSE in 1 CARTON / .1 mL in 1 VIAL, SINGLE-DOSE
Product Code
11-Digit Billing Format
85766007602
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Narcan
Non-Proprietary Name
Naloxone Hydrochloride Nasal
Substance Name
Naloxone Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
Usage Information
NARCAN ® Naloxone HCl Nasal Spray 4 mg Emergency Treatment of Opioid OverdoseImportant:For use in the nose onlyDo not test nasal spray device before use1 nasal spray device contains 1 dose of medicineEach device sprays 1 time onlyStep 1: CHECK if you suspect an overdose:CHECKfor a suspected overdose:the person will not wake up or is very sleepy or not breathing well yell “Wake up!”shake the person gentlyif the person is not awake, go to Step 2Step 2: Give 1st dose in the noseHOLDthe nasal spray device with your thumb on the bottom of the plunger INSERTthe nozzle into either NOSTRIL PRESSthe plunger firmly to give the 1st dose 1 nasal spray device contains 1 doseStep 3: CALL 911CALL 911immediately after giving the l stdose Step 4: WATCH & GIVEWAIT2-3 minutes after the l stdose to give the medicine time to work if the person wakes up: Go to Step 5 if the person does not wake up: CONTINUE TO GIVEdoses every 2-3 minutes until the person wakes up it is safe to keep giving dosesStep 5: STAYSTAYuntil ambulance arrives: even if the person wakes up GIVEanother dose if the person becomes very sleepy again You may need to give all the doses in the packFor opioid emergencies, call 911.For questions on NARCAN, call 1-844-4NARCAN (1-844-462-7226) or go to www.narcan.com. ©2023 Emergent Devices Inc. EMERGENT® and NARCAN® are registered trademarks of Emergent BioSolutions Inc, or its subsidiaries.Other Informationstore at room temperature or refrigerated, between 2°C to 25°C (36°F to 77°F)do not freezeavoid excessive heat above 40°C (104°F)protect from lightthe product is packaged in individually-sealed blisters. Do not use if the blister is open or torn, or if the device appears damaged.

Regulatory & Marketing

Labeler Name
Sportpharm Llc
Product Type
Human Otc Drug
FDA Application #
NDA208411
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-28-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85766-076-02 identifies a specific commercial package of 2 vial, single-dose in 1 carton / .1 ml in 1 vial, single-dose of Narcan, a human over the counter drug labeled by Sportpharm Llc. This spray is formulated for nasal use and contains naloxone hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sportpharm Llc on August 28, 2023. The current certification is valid through December 31, 2027.

How is this Sportpharm Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85766007602. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85766-076-02
11-Digit CMS (5-4-2)
85766-0076-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.